RCKT

NASDAQ · Biotechnology

Rocket Pharmaceuticals Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.44

+0.03 (+0.88%)

As of Aug 8, 1:59 AM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 11 55%

Hold 7 35%

Sell 2 10%

Price Target

Analyst Price Target +390.4% upside

Low Target $13.87

Average Target $16.87

High Target $23.44

Current Price $3.44

Current
$3.44

Target
$16.87

$13.87 $16.87 avg $23.44

Scenario Analysis

Bear Case

$13.87

303.2%

Low target

Base Case

$16.87

+390.4%

Avg target

Bull Case

$23.44

+581.4%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$5.45

-36.9% from high

52-Week Low

$2.53

+36.0% from low

Target vs 52W High

$16.87

+209.5% vs high

Next Earnings Report

Aug 10, 2026 · After Market Close

tomorrow

EPS Est: $0.38

Earnings in 1 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%